Titan Pharmaceuticals Inc (TTNP)

[KMBJN]

Hopefully Investors are sufficiently schooled to see through this

I'm hoping the FDA is sufficiently schooled to give them a difficult review, as they did for probuphine. How many Phase 3 studies did Titan have to do again, and why did we seemingly have to run several trials comparing our buprenorphine implant to sublingual buprenorphine but Indivior does not have to run a single one?

Somehow I'm cynical and skeptical that will happen, that FDA will give both implants an equally hard time. FDA has fast-tracked RBP-6000, and probably will approve it lickety-split (even without an active comparator trial???), AND I bet they get the appropriate codes and insurance approvals set up very quickly - unlikely the agonizingly slow approval and uptake by a small company like Titan/Braeburn.

I still think Titan's proneura technology should be a winner in the long run, and perhaps they will have much better luck navigating other diseases without so much politics and lobbying and buying of influence. Maybe this whole implant thing is just a new concept with resistance built into the system, and the next TTNP implant will be approved much more easily and quickly, with sales coming quicker ... one can hope.